EMEA (Europe, Middle East and Africa) Nuclear Medicine Market Report 2017

November 2017 | 107 pages | ID: EAD7A6E386FEN
QYResearch

Abstracts

In this report, the EMEA Nuclear Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Nuclear Medicine for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Nuclear Medicine market competition by top manufacturers/players, with Nuclear Medicine sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Mallinckrodt
• Medtronic
• General Electric
• GlaxoSmithKline
• Cardinal Health
• Lantheus Medical Imaging
• IBA

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Diagnostic
• Therapeutic

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Oncology
• Cardiology
• Neurology
• Thyroid
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Nuclear Medicine Market Report 2017

1 NUCLEAR MEDICINE OVERVIEW

1.1 Product Overview and Scope of Nuclear Medicine
1.2 Classification of Nuclear Medicine
  1.2.1 EMEA Nuclear Medicine Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Nuclear Medicine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Diagnostic
  1.2.4 Therapeutic
1.3 EMEA Nuclear Medicine Market by Application/End Users
  1.3.1 EMEA Nuclear Medicine Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Oncology
  1.3.3 Cardiology
  1.3.4 Neurology
  1.3.5 Thyroid
  1.3.6 Others
1.4 EMEA Nuclear Medicine Market by Region
  1.4.1 EMEA Nuclear Medicine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Nuclear Medicine (2012-2022)
  1.5.1 EMEA Nuclear Medicine Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Nuclear Medicine Revenue and Growth Rate (2012-2022)

2 EMEA NUCLEAR MEDICINE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Nuclear Medicine Market Competition by Players/Manufacturers
  2.1.1 EMEA Nuclear Medicine Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Nuclear Medicine Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Nuclear Medicine Sale Price by Players (2012-2017)
2.2 EMEA Nuclear Medicine (Volume and Value) by Type/Product Category
  2.2.1 EMEA Nuclear Medicine Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Nuclear Medicine Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Nuclear Medicine Sale Price by Type (2012-2017)
2.3 EMEA Nuclear Medicine (Volume) by Application
2.4 EMEA Nuclear Medicine (Volume and Value) by Region
  2.4.1 EMEA Nuclear Medicine Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Nuclear Medicine Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Nuclear Medicine Sales Price by Region (2012-2017)

3 EUROPE NUCLEAR MEDICINE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Nuclear Medicine Sales and Value (2012-2017)
  3.1.1 Europe Nuclear Medicine Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Nuclear Medicine Revenue and Growth Rate (2012-2017)
3.2 Europe Nuclear Medicine Sales and Market Share by Type
3.3 Europe Nuclear Medicine Sales and Market Share by Application
3.4 Europe Nuclear Medicine Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Nuclear Medicine Sales Volume by Countries (2012-2017)
  3.4.2 Europe Nuclear Medicine Revenue by Countries (2012-2017)
  3.4.3 Germany Nuclear Medicine Sales and Growth Rate (2012-2017)
  3.4.4 France Nuclear Medicine Sales and Growth Rate (2012-2017)
  3.4.5 UK Nuclear Medicine Sales and Growth Rate (2012-2017)
  3.4.6 Russia Nuclear Medicine Sales and Growth Rate (2012-2017)
  3.4.7 Italy Nuclear Medicine Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Nuclear Medicine Sales and Growth Rate (2012-2017)

4 MIDDLE EAST NUCLEAR MEDICINE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Nuclear Medicine Sales and Value (2012-2017)
  4.1.1 Middle East Nuclear Medicine Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Nuclear Medicine Revenue and Growth Rate (2012-2017)
4.2 Middle East Nuclear Medicine Sales and Market Share by Type
4.3 Middle East Nuclear Medicine Sales and Market Share by Application
4.4 Middle East Nuclear Medicine Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Nuclear Medicine Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Nuclear Medicine Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Nuclear Medicine Sales and Growth Rate (2012-2017)
  4.4.4 Israel Nuclear Medicine Sales and Growth Rate (2012-2017)
  4.4.5 UAE Nuclear Medicine Sales and Growth Rate (2012-2017)
  4.4.6 Iran Nuclear Medicine Sales and Growth Rate (2012-2017)

5 AFRICA NUCLEAR MEDICINE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Nuclear Medicine Sales and Value (2012-2017)
  5.1.1 Africa Nuclear Medicine Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Nuclear Medicine Revenue and Growth Rate (2012-2017)
5.2 Africa Nuclear Medicine Sales and Market Share by Type
5.3 Africa Nuclear Medicine Sales and Market Share by Application
5.4 Africa Nuclear Medicine Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Nuclear Medicine Sales Volume by Countries (2012-2017)
  5.4.2 Africa Nuclear Medicine Revenue by Countries (2012-2017)
  5.4.3 South Africa Nuclear Medicine Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Nuclear Medicine Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Nuclear Medicine Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Nuclear Medicine Sales and Growth Rate (2012-2017)

6 EMEA NUCLEAR MEDICINE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Mallinckrodt
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nuclear Medicine Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Mallinckrodt Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Medtronic
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Nuclear Medicine Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Medtronic Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 General Electric
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Nuclear Medicine Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 General Electric Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Nuclear Medicine Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GlaxoSmithKline Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Cardinal Health
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Nuclear Medicine Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Cardinal Health Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Lantheus Medical Imaging
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Nuclear Medicine Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Lantheus Medical Imaging Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 IBA
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Nuclear Medicine Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 IBA Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 NUCLEAR MEDICINE MANUFACTURING COST ANALYSIS

7.1 Nuclear Medicine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nuclear Medicine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nuclear Medicine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nuclear Medicine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NUCLEAR MEDICINE MARKET FORECAST (2017-2022)

11.1 EMEA Nuclear Medicine Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Nuclear Medicine Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Nuclear Medicine Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Nuclear Medicine Price and Trend Forecast (2017-2022)
11.2 EMEA Nuclear Medicine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Nuclear Medicine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Nuclear Medicine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Nuclear Medicine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Nuclear Medicine Sales Forecast by Type (2017-2022)
11.7 EMEA Nuclear Medicine Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Nuclear Medicine
Figure EMEA Nuclear Medicine Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Nuclear Medicine Sales Volume Market Share by Type (Product Category) in 2016
Figure Diagnostic Product Picture
Figure Therapeutic Product Picture
Figure EMEA Nuclear Medicine Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Nuclear Medicine by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Neurology Examples
Table Key Downstream Customer in Neurology
Figure Thyroid Examples
Table Key Downstream Customer in Thyroid
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Nuclear Medicine Market Size (Million USD) by Region (2012-2022)
Figure Europe Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Nuclear Medicine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Nuclear Medicine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Nuclear Medicine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Nuclear Medicine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Nuclear Medicine Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Nuclear Medicine Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Nuclear Medicine Sales Share by Players (2012-2017)
Figure 2016 Nuclear Medicine Sales Share by Players
Figure 2017 Nuclear Medicine Sales Share by Players
Figure EMEA Nuclear Medicine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Nuclear Medicine Revenue (Million USD) by Players (2012-2017)
Table EMEA Nuclear Medicine Revenue Share by Players (2012-2017)
Table 2016 EMEA Nuclear Medicine Revenue Share by Players
Table 2017 EMEA Nuclear Medicine Revenue Share by Players
Table EMEA Nuclear Medicine Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Nuclear Medicine Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Nuclear Medicine Sales Share by Type (2012-2017)
Figure Sales Market Share of Nuclear Medicine by Type (2012-2017)
Figure EMEA Nuclear Medicine Sales Market Share by Type (2012-2017)
Table EMEA Nuclear Medicine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Nuclear Medicine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nuclear Medicine by Type in 2016
Table EMEA Nuclear Medicine Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Nuclear Medicine Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Nuclear Medicine Sales Share by Application (2012-2017)
Figure Sales Market Share of Nuclear Medicine by Application (2012-2017)
Figure EMEA Nuclear Medicine Sales Market Share by Application in 2016
Table EMEA Nuclear Medicine Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Nuclear Medicine Sales Share by Region (2012-2017)
Figure Sales Market Share of Nuclear Medicine by Region (2012-2017)
Figure EMEA Nuclear Medicine Sales Market Share in 2016
Table EMEA Nuclear Medicine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Nuclear Medicine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Nuclear Medicine by Region (2012-2017)
Figure EMEA Nuclear Medicine Revenue Market Share Regions in 2016
Table EMEA Nuclear Medicine Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Nuclear Medicine Revenue and Growth Rate (2012-2017)
Table Europe Nuclear Medicine Sales (K Units) by Type (2012-2017)
Table Europe Nuclear Medicine Market Share by Type (2012-2017)
Figure Europe Nuclear Medicine Market Share by Type in 2016
Table Europe Nuclear Medicine Sales (K Units) by Application (2012-2017)
Table Europe Nuclear Medicine Market Share by Application (2012-2017)
Figure Europe Nuclear Medicine Market Share by Application in 2016
Table Europe Nuclear Medicine Sales (K Units) by Countries (2012-2017)
Table Europe Nuclear Medicine Sales Market Share by Countries (2012-2017)
Figure Europe Nuclear Medicine Sales Market Share by Countries (2012-2017)
Figure Europe Nuclear Medicine Sales Market Share by Countries in 2016
Table Europe Nuclear Medicine Revenue (Million USD) by Countries (2012-2017)
Table Europe Nuclear Medicine Revenue Market Share by Countries (2012-2017)
Figure Europe Nuclear Medicine Revenue Market Share by Countries (2012-2017)
Figure Europe Nuclear Medicine Revenue Market Share by Countries in 2016
Figure Germany Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure France Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure UK Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Nuclear Medicine Sales (K Units) by Type (2012-2017)
Table Middle East Nuclear Medicine Market Share by Type (2012-2017)
Figure Middle East Nuclear Medicine Market Share by Type (2012-2017)
Table Middle East Nuclear Medicine Sales (K Units) by Applications (2012-2017)
Table Middle East Nuclear Medicine Market Share by Applications (2012-2017)
Figure Middle East Nuclear Medicine Sales Market Share by Application in 2016
Table Middle East Nuclear Medicine Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Nuclear Medicine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Nuclear Medicine Sales Volume Market Share by Countries in 2016
Table Middle East Nuclear Medicine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Nuclear Medicine Revenue Market Share by Countries (2012-2017)
Figure Middle East Nuclear Medicine Revenue Market Share by Countries (2012-2017)
Figure Middle East Nuclear Medicine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Nuclear Medicine Sales (K Units) by Type (2012-2017)
Table Africa Nuclear Medicine Sales Market Share by Type (2012-2017)
Figure Africa Nuclear Medicine Sales Market Share by Type (2012-2017)
Figure Africa Nuclear Medicine Sales Market Share by Type in 2016
Table Africa Nuclear Medicine Sales (K Units) by Application (2012-2017)
Table Africa Nuclear Medicine Sales Market Share by Application (2012-2017)
Figure Africa Nuclear Medicine Sales Market Share by Application (2012-2017)
Table Africa Nuclear Medicine Sales Volume (K Units) by Countries (2012-2017)
Table Africa Nuclear Medicine Sales Market Share by Countries (2012-2017)
Figure Africa Nuclear Medicine Sales Market Share by Countries (2012-2017)
Figure Africa Nuclear Medicine Sales Market Share by Countries in 2016
Table Africa Nuclear Medicine Revenue (Million USD) by Countries (2012-2017)
Table Africa Nuclear Medicine Revenue Market Share by Countries (2012-2017)
Figure Africa Nuclear Medicine Revenue Market Share by Countries (2012-2017)
Figure Africa Nuclear Medicine Revenue Market Share by Countries in 2016
Figure South Africa Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Table Mallinckrodt Nuclear Medicine Basic Information List
Table Mallinckrodt Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mallinckrodt Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Mallinckrodt Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure Mallinckrodt Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table Medtronic Nuclear Medicine Basic Information List
Table Medtronic Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medtronic Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Medtronic Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure Medtronic Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table General Electric Nuclear Medicine Basic Information List
Table General Electric Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure General Electric Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure General Electric Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure General Electric Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Nuclear Medicine Basic Information List
Table GlaxoSmithKline Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table Cardinal Health Nuclear Medicine Basic Information List
Table Cardinal Health Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cardinal Health Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Cardinal Health Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure Cardinal Health Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table Lantheus Medical Imaging Nuclear Medicine Basic Information List
Table Lantheus Medical Imaging Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lantheus Medical Imaging Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Lantheus Medical Imaging Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure Lantheus Medical Imaging Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table IBA Nuclear Medicine Basic Information List
Table IBA Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure IBA Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure IBA Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure IBA Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine
Figure Manufacturing Process Analysis of Nuclear Medicine
Figure Nuclear Medicine Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine Major Manufacturers in 2016
Table Major Buyers of Nuclear Medicine
Table Distributors/Traders List
Figure EMEA Nuclear Medicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Nuclear Medicine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Nuclear Medicine Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Nuclear Medicine Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Nuclear Medicine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Nuclear Medicine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Nuclear Medicine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Nuclear Medicine Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Nuclear Medicine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Nuclear Medicine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Nuclear Medicine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Nuclear Medicine Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Nuclear Medicine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Nuclear Medicine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Nuclear Medicine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Nuclear Medicine Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Nuclear Medicine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Nuclear Medicine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Nuclear Medicine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Nuclear Medicine Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Nuclear Medicine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Nuclear Medicine Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Nuclear Medicine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources